Submission Details

Submitter:

Classification:
Moderate
GENCC:100003
Gene:
Disease:
myasthenic syndrome, congenital, 22
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
09/10/2019
Evidence/Notes:
The PREPL gene is located on chromosome 2 at 2p21 and encodes the prolyl endopeptidase like protein, which encodes a putative serine peptidase from the prolyl oligopeptidase family. The protein is ubiquitously expressed with higher levels found in the brain, kidney, and muscle, however, the biological role of the PREPL is yet to be fully elucidated. PREPL was first reported in relation to autosomal recessive isolated PREPL-related myasthenic syndrome, congenital in 2018 (28726805: Regal et al. 2018). Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least six unique variants including deletion, frameshift, and splice variants have been reported in four probands from three publications (28726805: Regal et al. 2018; 29483676: Silva et al. 2018; 29913539: Laugwitz et al. 2018). All variants were found in either a homozygous state or a compound heterozygous state with a second deleterious variant. This gene-disease relationship is supported by expression studies that demonstrate colocalization of PREPL with alpha bungarotoxin within muscle fibers and at the endplates (24610330: Regal et al. 2014) and Prepl knockout mice that recapitulate the key features of the disorder including stunted growth and neonatel hypotonia which resolves over time (24586561: Lone et al. 2014). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged.
PubMed IDs:
28726805 29483676 29913539 24610330 24586561
Assertion Criteria:
Submitter Submitted Date:
10/15/2020

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.